SCHEMBL2466802

SCHEMBL2466802

CC(C)C(OC(=O)c1ccc(F)cc1)C(CNC(=O)c1ccc(F)cc1)C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
ALOX12 P18054 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MLYCD O95822 1/20 0.45
HPGD P15428 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ADRB2 P07550 2/20 0.43
ADRB1 P08588 2/20 0.43
ADRB3 P13945 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ATM Q13315 1/20 0.43
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
MEN1 O00255 1/20 0.41
EPHX2 P34913 1/20 0.41
TP53 P04637 2/20 0.41
MAPT P10636 2/20 0.41
ACSS2 Q9NR19 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2468948 0.90 ALDH1A1 (0.45) ALDH1A1ALOX12SMN1; SMN2MLYCDHPGD
SCHEMBL2466789 0.87 MEN1 (0.46) ALDH1A1ALOX12SMN1; SMN2MLYCDHPGD
SCHEMBL2464965 0.87 ADRB2 (0.43) ALDH1A1ALOX12SMN1; SMN2MLYCDHPGD
SCHEMBL2470781 0.85 ALDH1A1 (0.44) ALDH1A1ALOX12SMN1; SMN2MLYCDHPGD
SCHEMBL14243769 0.85 SLC6A9 (0.44) ALDH1A1ALOX12SMN1; SMN2MLYCDHPGD
SCHEMBL2467776 0.82 ALDH1A1 (0.46) ALDH1A1ALOX12SMN1; SMN2MLYCDHPGD
SCHEMBL2465585 0.82 SLC6A9 (0.46) ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL2465537 0.81 NPC1 (0.51) ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL2539486 0.78 ALDH1A1 (0.47) ALDH1A1ALOX12SMN1; SMN2MLYCDHPGD
SCHEMBL2462474 0.78 ALDH1A1 (0.44) ALDH1A1ALOX12SMN1; SMN2MLYCDHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2539378-B1 HALOGENATED AMIDE ESTER AND INTERNAL ELECTRON DONOR WITH SAME GRACE W R & CO (US) 2018-06-06 EP disclosed
US-8466081-B2 Halogenated amide ester and internal electron donor with same DOW GLOBAL TECHNOLOGIES LLC (US) 2013-06-18 US disclosed
EP-2539378-A1 HALOGENATED AMIDE ESTER AND INTERNAL ELECTRON DONOR WITH SAME Dow Global Technologies LLC (US) 2013-01-02 EP disclosed
US-20120322964-A1 Halogenated Amide Ester and Internal Electron Donor with Same DOW GLOBAL TECHNOLOGIES LLC (US) 2012-12-20 US disclosed
WO-2011106497-A1 HALOGENATED AMIDE ESTER AND INTERNAL ELECTRON DONOR WITH SAME DOW GLOBAL TECHNOLOGIES LLC (US) 2011-09-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322964-A1 Halogenated Amide Ester and Internal Electron Donor with Same NAT10, NAT1, NAA50 ALDH1A1 701/4885ALOX12 249/4885SMN1; SMN2 3716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.